Altimmune Inc (NQ: ALT )
7.540
+1.050
(+16.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
All News about Altimmune Inc
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image-lucid_group.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/16/aapharma_5.png?width=1200&height=800&fit=crop)
Recent Selloff Is A 'Buying Opportunity' For This NASH Stock, Says Analyst
September 16, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26722.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600b.jpg)
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/710145/cost-vs-value.jpg)
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2022/09/14/aapharma_5.png?width=1200&height=800&fit=crop)
Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/26/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26785.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/15/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16972.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image14.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/02/twlo_twilio_3_1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image12.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/lab-g43dd1823c_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16925.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2011.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/09/Stock-Sarepta-Boston01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/15/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8418.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/image30.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.